Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
+2.11M
-
Total reported value, excl. options
-
$1.74B
-
Value change
-
-$42.4M
-
Put/Call ratio
-
1.4
-
Number of buys
-
126
-
Number of sells
-
-84
-
Price
-
$13.88
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q1 2022
252 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q1 2022.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 152M outstanding shares and own 82.68% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.4M shares), Matrix Capital Management Company, LP (11.6M shares), VANGUARD GROUP INC (11.1M shares), ARK Investment Management LLC (7.71M shares), BlackRock Inc. (5.97M shares), Nikko Asset Management Americas, Inc. (4.14M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.13M shares), Bellevue Group AG (3.15M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.88M shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.